Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Epidemiology of Parkinson's disease.

Author information

Affiliations

  • 1. Clinical Center for Parkinson's Disease and Movement Disorders, California Parkinson's Foundation, San Jose.
      Authors
    • Tanner CM 1
    (1 author)

Neurologic Clinics, 01 May 1992, 10(2):317-329
https://doi.org/10.1016/s0733-8619(18)30212-3 PMID: 1584176 PMCID: PMC7172502

Review

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Abstract 

Additional epidemiologic studies may provide important insights into the etiology of Parkinson's disease. Moreover as the elderly population of Europe and the United States grows, accurate public health planning requires accurate incidence and prevalence estimates. The recent development of a therapy that may slow disease progression (see article by Tetrud elsewhere in this issue) makes early identification and treatment of Parkinson's disease particularly important. Investigations of early markers of Parkinson's disease or markers of disease susceptibility are critical areas of future research, requiring careful collaboration between epidemiologists and laboratory scientists.

Free full text 

Logo of pheelsevierLink to Publisher's site
Neurol Clin. 1992 May; 10(2): 317–329.
PMCID: PMC7172502
PMID: 1584176

Epidemiology of Parkinson’s Disease

Caroline M. Tanner, MD*
Author information Copyright and License information Disclaimer

Abstract

The major source of error in epidemiologic studies of Parkinson’s disease is diagnostic uncertainty. Prevalence varies widely in community-based studies, ranging from 31 per 100,000 persons in Libya to 328 per 100,000 persons in the Par si community in Bombay, India, possibly reflecting the differences in risk factors among the populations studied, in addition to the methodologic differences. Parkinson’s disease is common with advancing age. Heredity may be a risk factor in some cases, and whites may be more susceptible. The many controlled studies examining the increased risk for this disease are discussed.

References

1. Aquilonius S.M., Hartvig P. A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand. 1986;74:379–382. [Abstract] [Google Scholar]
2. Ashok P.P., Radhakrishan K., Sridharan R. Parkinsonism in Benghazi, East Libya. Clin Neurol Neurosurg. 1986;88:109–113. [Abstract] [Google Scholar]
3. Barbeau A., Pourcher E. New data on the genetics of Parkinson’s disease. Can J Neurol Sei. 1982;9:53–60. [Abstract] [Google Scholar]
4. Barbeau A., Roy M. Uneven prevalence of Parkinson’s disease in the province of Quebec. Can J Neurol Sei. 1985;12:169. [Google Scholar]
5. Baumann R.J., Jameson H.D., McKean H.E. Cigarette smoking and Parkinson’s disease: I. A comparison of cases with matched neighbors. Neurology. 1980;30:839–843. [Abstract] [Google Scholar]
6. Bharucha N.E., Bharucha E.P., Bharucha A.E. Prevalence of Parkinson’s disease in the Parsi community of Bombay, India. Arch Neurol. 1988;45:1321–1323. [Abstract] [Google Scholar]
7. Bharucha N.E., Stokes L., Schoenberg B.S. A case-control study of twin pairs discordant for Parkinson’s disease: A search for environmental risk factors. Neurology. 1986;36:284–288. [Abstract] [Google Scholar]
8. Brewis M., Poskanzer D.C., Rolland C. Neurological disease in an English city. Acta Neurol Scand. 1966;42(suppl 24):9–89. [Abstract] [Google Scholar]
9. Burch P.R.J. Cigarette smoking and Parkinson’s disease. Neurology. 1981;31:500–503. [Abstract] [Google Scholar]
10. Campanella G., Filla A., De Michele G. Etiology of Parkinson’s disease: Results of two case-control studies. Movement Dis. 1990;5(suppl 1):31. [Google Scholar]
11. Chandra V., Kokmen E., Schoenberg B. Head trauma with loss of consciousness as a risk factor for Alzheimer’s disease. Neurology. 1989;39:1576–1578. [Abstract] [Google Scholar]
12. Charcot J.M. The New Sydenham Society; London: 1878. Lectures on the Diseases of the Nervous System, Vol I. English translation by Sigerson G. [Google Scholar]
13. Cross C.E., Halliwell B., Borish E.T. Oxygen radicals and human disease. Ann Intern Med. 1987;107:526–545. [Abstract] [Google Scholar]
14. D’Alessandro R., Gamberini G., Granieri E. Prevalence of Parkinson’s disease in the Republic of San Marino. Neurology. 1987;37:1679–1682. [Abstract] [Google Scholar]
15. Davanipour Z., Will A.D. Residential histories in Parkinson’s disease patients. Ann Neurology. 1990;28:295. [Google Scholar]
16. Dulaney E., Stern M., Hurtig H. The epidemiology of Parkinson’s disease: A case-control study of young-onset versus old-onset patients. Movement Dis. 1990;5(suppl 1):12. [Abstract] [Google Scholar]
17. Ehmeier K.P., Mutch W.J., Calder S.A. Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza? J Neurol Neurosurg Psych. 1989;52:911–913. [Europe PMC free article] [Abstract] [Google Scholar]
18. Elizan T.S., Casals J. The viral hypothesis in Parkinson’s disease in Alzheimer’s disease: A critique. In: Kurstak E., Lipowski S.J., Morozov P.V., editors. Viruses, Immunity and Mental Disorders. Plenum Press; New York: 1987. pp. 47–59. [Google Scholar]
19. Fazzini E., Fleming J., Fahn S. Cerebrospinal fluid antibodies to coronaviruses in patients with Parkinson’s disease. Neurology. 1990;40(suppl 1):169. [Google Scholar]
20. Gibberd F.B., Simmons J.P. Neurological disease in ex-Far-East prisoners of war. Lancet. 1980;2:135–138. [Abstract] [Google Scholar]
21. Godwin-Austin R.B., Lee P.N., Marmot M.G. Smoking and Parkinson’s disease. J Neurol Neurosurg Psych. 1982;45:577–581. [Europe PMC free article] [Abstract] [Google Scholar]
22. Goetz C.G. SP Medical and Scientific Books; New York: 1985. Neurotoxins in Clinical Practice; p. xix. [Google Scholar]
23. Goetz C.G. Motor vehicle accident and Parkinson’s disease disability. Movement Dis. 1990;5(suppl 1):16. [Google Scholar]
24. Golbe L.I., Cody R.A., Duvoisin R.C. Smoking and Parkinson’s disease. Search for a dose-response relationship. Arch Neurol. 1986;43:774–778. [Abstract] [Google Scholar]
25. Golbe L.I., Di Torio G., Bonavita V. A large kindred with autosomal dominant Parkinson’s disease. Ann Neurol. 1990;27:276–282. [Abstract] [Google Scholar]
26. Golbe L.I., Farrell T.M., Davis P.H. Case-control study of early life dietary factors in Parkinson’s disease. Arch Neurol. 1988;45:350–353. [Abstract] [Google Scholar]
27. Golbe L.I., Farrell T.M., Davis P.H. Follow-up study of early life protective and risk factors in Parkinson’s disease. Movement Dis. 1990;5:66–70. [Abstract] [Google Scholar]
28. Gowers W.R. P. Blakiston, Son & Company; Philadelphia: 1888. Diseases of the Nervous System. American Edition. [Google Scholar]
29. Gudmundsson K.R. A clinical survey of parkinsonism in Iceland. Acta Neurol Scand. 1967;33:9–61. [Abstract] [Google Scholar]
30. Haack D.G., Baumann R.J., McKean H.E. Nicotine exposure and Parkinson’s disease. Am J Epidemiol. 1981;114:119–200. [Abstract] [Google Scholar]
31. Harada H., Nishikawa S., Takahashi K. Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol. 1983;40:151–154. [Abstract] [Google Scholar]
32. Hertzman C., Wiens M., Bowering D. Parkinson’s disease: A case-control study of occupational and environmental risk factors. Am J Indust Med. 1990;17:349–355. [Abstract] [Google Scholar]
33. Ho S.C., Woo J., Lee C.M. Epidemiologic study of Parkinson’s disease in Hong Kong. Neurology. 1989;39:1314–1318. [Abstract] [Google Scholar]
34. Jenkins A.C. Epidemiology of parkinsonism in Victoria. Med J Australia. 1966;2:497–502. [Abstract] [Google Scholar]
35. Jimenez-Jimenez F.J., Gonzales D.M., Gimenez-Roldan S. Proceedings of the Ninth International Symposium on Parkinson’s Disease. Israel World Congress of Neurology; Jerusalem: 1988. Exposure to well water drinking and pesticides in Parkinson’s disease. A case-control study from the southeast area of Madrid; p. 118. [Google Scholar]
36. Kahn H.A. National Cancer Institute: Epidemiologic Approaches to the Study of Cancer and other Diseases. US Government Printing Office, Monograph 19; Washington, DC: 1966. The Dorn Study of smoking among US veterans; pp. 1–125. [Abstract] [Google Scholar]
37. Kessler I.I. Epidemiologic studies of Parkinson’s disease. II. A hospital-based survey. Am J Epidemiol. 1972;95:308–318. [Abstract] [Google Scholar]
38. Kessler I.I. Epidemiologic studies of Parkinson’s disease. III. A community-based survey. Am J Epidemiol. 1972;96:242–254. [Abstract] [Google Scholar]
39. Kessler I.I., Diamond E.L. Epidemiologic studies of Parkinson’s disease. I. Smoking and Parkinson’s disease: A survey and explanatory hypothesis. Am J Epidemiol. 1971;94:16–25. [Abstract] [Google Scholar]
40. Koller W.C. Classification of parkinsonism. In: Koller W.C., editor. Handbook of Parkinson’s Disease. Marcel Dekker; New York: 1987. pp. 51–80. [Google Scholar]
41. Koller W., Vetere-Overfield B., Gray C. Environmental risk factors in Parkinson’s disease. Neurology. 1990;40:1218–1221. [Abstract] [Google Scholar]
42. Kondo K., Kurland L., Schull W. Parkinson’s disease: Genetic analysis and evidence of a multifactorial etiology. Mayo Clin Proc. 1973;48:465–475. [Abstract] [Google Scholar]
43. Kurland L.T. Epidemiology: Incidence, geographic distribution and genetic considerations. In: Field W., editor. Pathogenesis and Treatment of Parkinsonism. Charles C Thomas; Springfield: 1958. pp. 5–43. [Google Scholar]
44. Langston J.W., Ballard P.A., Tetrud J.W. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979–980. [Abstract] [Google Scholar]
45. Li S.C., Schoenberg B.S., Wang C.C. A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol. 1985;42:655–657. [Abstract] [Google Scholar]
46. Marsden C.D. Twins and Parkinson’s disease. J Neurol Neurosurg Psych. 1987;50:105–106. [Europe PMC free article] [Abstract] [Google Scholar]
47. Martin W.E., Young W.I., Anderson V.E. Parkinson’s disease: A genetic study. Brain. 1973;96:495–506. [Abstract] [Google Scholar]
48. Marttila R.J., Halonen P., Rinne U.K. Influenza virus antibodies in parkinsonism. Arch Neurol. 1977;34:99–100. [Abstract] [Google Scholar]
49. Marttila R.J., Kaprio J., Koshewvuo M., Rinne U.K. Parkinson’s disease in a nationwide twin cohort. Neurology. 1988;38:1217–1219. [Abstract] [Google Scholar]
50. Marttila R.J., Rinne U.K. Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand. 1967;43(suppl 33):9–61. [Abstract] [Google Scholar]
51. Mattock C., Marmot M., Stern G. Could Parkinson’s disease follow intrauterine influenza? A speculative hypothesis. J Neurol Neurosurg Psych. 1988;51:753–756. [Europe PMC free article] [Abstract] [Google Scholar]
52. Mjones H. Paralysis agitans: A clinical and genetic study. Acta Psych Neurol. 1949;54(suppl):1–194. [Google Scholar]
53. Mutch W.J., Dingwall-Fordyce I., Downie A.W. Parkinson’s disease in a Scottish city. Br Med J. 1986;292:534–536. [Europe PMC free article] [Abstract] [Google Scholar]
54. Nefzinger M.D., Quadfasel F.A., Karl V.C. A retrospective study of smoking and Parkinson’s disease. Am J Epidemiol. 1968;88:149–158. [Abstract] [Google Scholar]
55. Okada K., Kobayashi S., Tsunematsu T. Prevalence of Parkinson’s disease in Izumo City, Japan. Gerontology. 1990;36:340–344. [Abstract] [Google Scholar]
56. Osuntokun B.O. The pattern of neurological illness in tropical Africa: Experience at Ibadan, Nigeria. J Neurol Sei. 1971;12:417. [Abstract] [Google Scholar]
57. Paddison R.M., Griffith R.P. Occurrence of Parkinson’s disease in black patients at Charity Hospital in New Orleans. Neurology. 1974;24:688–690. [Abstract] [Google Scholar]
58. Parkinson J. Sherwood, Neely and Jones; London: 1817. An Essay on the Shaking Palsy. [Google Scholar]
59. Poskanzer D.C., Schwab R.S., Fraser D.W. Further observations on the cohort phenomenon in Parkinson’s syndrome. In: Barbeau A., Brunette J.R., editors. Progress in Neurogenetics. Excerpta Medica Foundation; Amsterdam: 1969. pp. 497–505. [Google Scholar]
60. Rajput A.H., Offord K.P., Beard M.C., Kurland L.T. Epidemiology of Parkinson’s disease. Incidence, classification and mortality. Ann Neurol. 1984;16:278–287. [Abstract] [Google Scholar]
61. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson’s disease. Neurology. 1987;37:226–232. [Abstract] [Google Scholar]
62. Rajput A.H., Uitti R.J., Stern W., Laverty W. Early onset of Parkinson’s disease in Saskatchewan—environmental considerations for etiology. Can J Neurol Sei. 1986;13:312–316. [Abstract] [Google Scholar]
63. Rocca W.A., Morgante M., Grigoletto F. Prevalence of Parkinson’s disease and other parkinsonisms: A door-to-door survey in two Sicilian communities. Neurology. 1990;40(suppl 1):422. [Google Scholar]
64. Rosati G., Granieri E., Pinna L. The risk of Parkinson disease in Mediterranean people. Neurology. 1980;30:250–255. [Abstract] [Google Scholar]
65. Schlesselman J.J. Oxford University Press; New York: 1982. Case-Control Studies: Design, Conduct, Analysis. [Google Scholar]
66. Schoenberg B.S., Anderson D.W., Haerer A.F. Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology. 1985;35:841–845. [Abstract] [Google Scholar]
67. Schoenberg B.S., Osuntokun B.O., Adeuja A.O.G. Comparison of the prevalence of Parkinson’s disease in black populations in the rural US and in rural Nigeria: Door-to-door community studies. Neurology. 1988;38:645–646. [Abstract] [Google Scholar]
68. Snyder A.M., Strieker E.M., Zigmond M.J. Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol. 1985;18:544–551. [Abstract] [Google Scholar]
69. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: Implications for Parkinson’s disease. Proceedings of the National Academy of Sciences. 1989;86:1398–1400. [Europe PMC free article] [Abstract] [Google Scholar]
70. Sutcliffe R.L.G., Prior R., Mawby B., McQuillan W.J. Parkinson’s disease in the district of the Northampton Health Authority, United Kingdom. Acta Neurol Scand. 1985;72:363–379. [Abstract] [Google Scholar]
71. Tanner C.M., Chen B., Cohen J.A. Dietary antioxidant vitamins and the risk of developing Parkinson’s disease. Neurology. 1989;39(suppl):181. [Google Scholar]
72. Tanner C.M., Chen B., Wang W. Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sei. 1987;14:419–423. [Abstract] [Google Scholar]
73. Tanner C.M., Chen B., Wang W. Environmental factors and Parkinson’s disease: A case-control study in China. Neurology. 1989;39:660–664. [Abstract] [Google Scholar]
74. Tanner C.M., Cohen J.C., Summerville B.C., Goetz C.G. Vitamin use and Parkinson’s disease. Ann Neurol. 1988;233:182. [Google Scholar]
75. Tanner C.M., Grabler P., Goetz C.G. Occupation and the risk of Parkinson’s disease: a case-control study in young onset patients. Neurology. 1990;40(suppl 1):422. [Google Scholar]
76. Tanner C.M., Koller W.C., Gilley D.C. Cigarette smoking, alcohol drinking and Parkinson’s disease: Cross-cultural risk assessment. Movement Dis. 1990;5(suppl 1):11. [Google Scholar]
77. Treves T.A., Rabey J.M., Korczyn A.D. Case-control study, with use of temporal approach, for evaluation of risk factors for Parkinson’s disease. Movement Dis. 1990;5(suppl 1):11. [Google Scholar]
78. Vierregge P., Schiffke A., Kompf D. Parkinson’s disease in twins. Neurology. 1991;41(suppl):255. [Google Scholar]
79. Ward C.D., Duvoisin R.C., Ince S.E. Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983;33:815–824. [Abstract] [Google Scholar]
80. Wong G.F., Gray C.S., Hassanein R.S., Koller W.C. Environmental risk factors in siblings with Parkinson’s disease. Arch Neurol. 1991;48:287–289. [Abstract] [Google Scholar]
81. Zayed J., Ducic S., Campanella G. Facteurs environnementaux dans l’etiologie de la maladie de Parkinson. Can J Neurol Sei. 1990;17:286–291. [Abstract] [Google Scholar]
82. Zimmerman T.R., Bhatt M., Caine D.B., Duvoisin R.C. Parkinson’s disease in monozygotic twins: A followup. Neurology. 1991;41(suppl):255. [Google Scholar]

Full text links 

Read article at publisher's site: https://doi.org/10.1016/s0733-8619(18)30212-3

Citations & impact 

Impact metrics

71
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (71) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.